Rein Therapeutics Inc. (RNTX) P/B ratio

P/B ratio · fiscal 2024
4.4×

The P/B ratio of Rein Therapeutics Inc. (RNTX) was 4.4× at the end of fiscal 2024 (December 31, 2024). That is 115.9% higher than the 2.0× of fiscal 2023. Figures as of 18 Nov 2026, 10:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio, fiscal 2024
4.4×
Change on fiscal 2023
+115.9%
Highest on record
4.4×fiscal 2024
Lowest on record
0.6×fiscal 2022
Fiscal years on record
42021–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Rein Therapeutics Inc. P/B ratio, in more detail

Across the 4 fiscal year-ends on record (2021–2024), the highest was 4.4× in fiscal 2024 and the lowest 0.6× in fiscal 2022.

History · 4 fiscal years

P/B ratio at each fiscal year-end

Rein Therapeutics Inc. P/B ratio, year by year

Rein Therapeutics Inc. (RNTX) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
2025——$1.16-$1.10
20244.4× 115.9% up$2.30$0.52
20232.0× 252.4% up$3.05$1.50
20220.6× 49.3% down$2.37$4.10
20211.1×—$11.26$9.89
2020——$20.80—
2019——$11.46—
2018——$16.80—
2017——$210.80—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on RNTX

Rein Therapeutics Inc., figure by figure

Rein Therapeutics Inc. (RNTX) overview: price, valuation and scorecard

Rein Therapeutics Inc. P/B ratio: questions and answers

What is Rein Therapeutics Inc.'s P/B ratio?

The P/B ratio of Rein Therapeutics Inc. (RNTX) was 4.4× at the end of fiscal 2024 (December 31, 2024). That is 115.9% higher than the 2.0× of fiscal 2023.

What are the highest and lowest P/B ratio figures on record for Rein Therapeutics Inc.?

Across the 4 fiscal year-ends on record (2021–2024), the highest was 4.4× in fiscal 2024 and the lowest 0.6× in fiscal 2022.

How is Rein Therapeutics Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Rein Therapeutics Inc. it is on record here for 4 fiscal years, 2021 to 2024.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Rein Therapeutics Inc. (RNTX) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/RNTX/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.